85 results
Page 3 of 5
6-K
EX-99.2
8e85m
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
xoq4daob1jiza ufl0
12 Jul 21
New post-hoc analyses of data from SELECTION Phase 3 program presented at European Crohn’s and Colitis Organisation (ECCO) virtual congress
9:02am
6-K
EX-99.1
ai1l0zpan8
4 Jun 21
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
6:05am
6-K
EX-99.1
rlpp4 qqi0k4956cva84
28 May 21
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress
6:00am
6-K
EX-99.1
n115cpv8mheaj7d
19 May 21
Current report (foreign)
6:00am
6-K
EX-99.3
fztuc2whpo2k0ul6d
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.2
h2i3sa raz3wr9wvr
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
veswbimlm9o7
23 Apr 21
Current report (foreign)
6:05am
6-K
EX-99.1
nts826k
15 Dec 20
Current report (foreign)
4:55pm
6-K
EX-99.2
rusdahxo8p1aw
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.1
b0b9dhaigwdmgw7
3 Nov 20
Current report (foreign)
6:00am
6-K
EX-99.2
7r244g 2n94vrbe8g8xu
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.1
7la65d s82jd
24 Jul 20
Current report (foreign)
9:45am
6-K
EX-99.2
ebqx24g9b0ahaosl
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.1
vd8f37nj2t1k
29 Jan 20
Current report (foreign)
6:05am
6-K
EX-99.2
eqdg8tnm
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.9
tmm94u
20 Sep 19
Current report (foreign)
4:07pm
6-K
EX-99.1
blkrgeopafn9qvqkeo0
5 Sep 19
European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis
5:24pm